Efficacy Analysis of Percutaneous Endoscopic Spinal Surgery for Young Patients with Discogenic Low Back Pain
Jianan Zhang,Qichang Li,Yu Du,Zhengjian Yan,Liang Chen,Liyuan Wang
DOI: https://doi.org/10.2147/JPR.S351296
IF: 2.8319
2022-03-03
Journal of Pain Research
Abstract:Jianan Zhang, 1 Qichang Li, 1 Yu Du, 1 Zhengjian Yan, 1 Liang Chen, 2 Liyuan Wang 1 1 Department of Orthopedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China; 2 Department of Musculoskeletal Tumor, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, 400030, People's Republic of China Correspondence: Liyuan Wang, Department of Orthopedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China, Tel +89-13648380803, Email Purpose: To evaluate the application value of percutaneous endoscopic spinal surgery for young patients with discogenic low back pain (DLBP) and to judge its clinical efficacy. Methods: We retrospectively analyzed young patients with single-segment discogenic lumbago from July 2018 to June 2020 in our department who underwent percutaneous endoscopic surgery according to the inclusion and exclusion criteria. We finally enrolled 20 patients. The follow-up time was 6– 30 months. In all patients, we recorded the visual analog scale (VAS) score for waist pain and the Oswestry Disability Index (ODI) preoperatively, immediately postoperatively and at the last follow-up. We used the modified MacNab criteria to assess the curative effect at the last follow-up. Results: All 20 patients underwent successful operations without complications. No recurrence was observed during follow-up. The VAS score of low back pain was 5.05± 1.19 points before surgery, 1.50± 051 points immediately after surgery, and 1.10± 0.72 points at the last follow-up (P < 0.05 preoperative vs both postoperative). At the last follow-up, the VAS scores of all 20 patients were ≤ 2, and 4 patients had no pain. The ODI was 46.66± 7.03% before surgery, 9.78± 4.05% immediately after surgery, and 4.11± 3.18% at the last (P < 0.05, preoperative vs both postoperative). According to the evaluation under the modified MacNab standard, the good–excellent rate of clinical efficacy at the last follow-up was 95%. Conclusion: Percutaneous endoscopic spinal surgery can significantly improve the symptoms and dysfunction of young patients with DLBP and has little effect on the biomechanical stability of the lumbar spine. This surgery has great clinical application value. Keywords: percutaneous endoscopic spinal surgery, discogenic low back pain, young patients, transforaminal, interlaminar At present, there are many controversies about the treatment of discogenic low back pain. This study retrospectively analyzed the efficacy of percutaneous endoscopic spinal surgery for young patients with discogenic low back pain, and the results show that this method is effective in the short and medium term. Discogenic low back pain (DLBP) is a kind of chronic nonspecific low back pain with a high incidence. 1,2 It is mainly resting low back pain caused by structural and functional disorders of the disc due to intervertebral disc degeneration. With the increase in unhealthy living and working styles in modern times, patients are showing DLBP earlier in life. Long-term chronic pain has a great impact on quality of life, causing a great burden on the social economy and other aspects of life, and it can even cause disability. 1–3 In essence, DLBP is caused by a series of pathological changes caused by disc degeneration. Due to the long-term bad posture of the young patients, the intervertebral disc showed a series of degenerative reactions, such as dehydration of the nucleus pulposus and "black", the formation of annulus fissure, the formation of pannus mediated by inflammatory factors, and the entry of nerve endings into annulus fibrosus with inflammatory granulation tissue. When a large amount of water is lost in the nucleus pulposus, components such as hyaluronic acid, keratinized sulfate, glycoprotein and collagen fibers also change accordingly, leading to changes such as intervertebral disc thinning, structural destruction, height reduction and annulus fibrosus rupture. 3 As the annulus ruptures, the autoimmune system recognizes and produces inflammatory mediators. 4–6 Induction of inflammatory mediators promotes the formation of local pannus and granulation tissue and stimulates nerve fiber endings to enter the annulus fibrosus, leading to low back pain. 7,8 There is much debate about the diagnosis and treatment of DLBP, and the current treatment strategies are mainly divided into two types: nonsurgical treatment and surgical treatment. 2,3,9 Nonsurgical treatment includes drug therapy, functional exercise, massage and acupuncture, but they often have a -Abstract Truncated-
clinical neurology